Trigyn Technologies Downgraded to 'Sell' by MarketsMOJO Due to Poor Growth and Expensive Valuation

Jul 23 2024 06:24 PM IST
share
Share Via
Trigyn Technologies, a microcap IT software company, has been downgraded to a 'Sell' by MarketsMojo due to poor long-term growth and an expensive valuation. The company's negative annual growth rate and low return on equity indicate an overvalued stock. Its below-par performance and lack of institutional investors also contribute to the downgrade.
Trigyn Technologies, a microcap IT software company, has recently been downgraded to a 'Sell' by MarketsMOJO on July 23, 2024. This decision was based on several factors, including poor long-term growth and an expensive valuation.

According to MarketsMOJO, Trigyn Technologies has shown a negative annual growth rate of -2.13% over the last 5 years in terms of operating profit. Additionally, the company's return on equity (ROE) is only 2.8, indicating an expensive valuation with a price to book value of 0.6. This means that the stock is trading at a premium compared to its historical valuations.

In the past year, Trigyn Technologies has generated a return of -4.39%, while its profits have fallen by -42.6%. This below-par performance has also been reflected in the company's long-term and near-term performance, as it has underperformed the BSE 500 index in the last 3 years, 1 year, and 3 months.

Other factors that may have contributed to the downgrade include the company's low debt to equity ratio and its strong cash position. Trigyn Technologies has a debt to equity ratio of 0, indicating a low level of debt. Additionally, the company's cash and cash equivalents have grown to Rs 336.18 crore, the highest in the last half-year.

From a technical standpoint, the stock's trend is currently sideways, indicating no clear price momentum. This trend has deteriorated from mildly bullish on July 23, 2024, and has generated a return of -4.21% since then.

It is also worth noting that the majority of Trigyn Technologies' shareholders are non-institutional investors. This may suggest a lack of confidence in the company's future prospects.

In conclusion, based on the above factors, MarketsMOJO has downgraded its stock call on Trigyn Technologies to 'Sell'. Investors should carefully consider these factors before making any investment decisions.
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News